Literature DB >> 12608942

The outcome in Australian children with hyperinsulinism of infancy: early extensive surgery in severe cases lowers risk of diabetes.

Michelle M Jack1, Ristan M Greer, Michael J Thomsett, Rosslyn M Walker, John R Bell, Catherine Choong, David M Cowley, Adrian C Herington, Andrew M Cotterill.   

Abstract

AIMS: Hyperinsulinism of infancy (HI) is characterized by unregulated insulin secretion in the presence of hypoglycaemia, often resulting in brain damage. Pancreatic resection for control of hypoglycaemia is frequently resisted because of the risk of diabetes mellitus (DM). We investigated retrospectively 62 children with HI from nine Australian treatment centres born between 1972 and 1998, comparing endocrine and neurological outcome in 28 patients receiving medical therapy alone with 34 who required pancreatic resection to control their hypoglycaemia.
METHODS: History, treatment and clinical course were ascertained from file audit and interview. Risk of DM (hazard ratio) attributable to age at surgery (< vs. > or = 100 days at last pancreatectomy) and extent of resection (< vs. > or = 95%) were calculated using Cox proportional hazards regression and categorical variables compared by the chi2-test. Neurological outcome (normal, mild deficit or severe deficit) was derived from the most authoritative source.
RESULTS: Surgically treated patients had a greater birthweight, earlier presentation and higher plasma insulin levels. Of 18 infants < 100 days and 16 > or = 100 days of age at surgery, four (all > or = 100 days) became diabetic as an immediate consequence of surgery and five (two < 100 days and three > or = 100 days) became diabetic 7-18 years later. Surgery > or = 100 days and pancreatectomy > or = 95% were associated with development of diabetes (HR = 12.61, CI 1.53-104.07 and HR = 7.03, CI 1.43-34.58, respectively). Neurodevelopmental outcome was no different between the surgical and medical groups with 44% overall with neurological deficits. Patients euglycaemic within 35 days of the first symptom of hypoglycaemia (Group A) had a better neurodevelopmental outcome than those still hypoglycaemic > 35 days from first presentation (Group B) (P = 0.007). Prolonged hypoglycaemia in Group B was due either to delayed diagnosis or to need for repeat surgery because of continued hypoglycaemia. Within Group A, medically treated patients (who presented later with apparently milder disease) had a higher incidence of neurodevelopmental deficit (n = 15, four mild, three severe deficit) compared with surgically treated patients (n = 18, two mild, none severe deficit) (P < 0.025).
CONCLUSIONS: Poor neurodevelopmental outcome remains a major problem in hyperinsulinism of infancy. Risk of diabetes mellitus with pancreatectomy varies according to age at surgery and extent of resection. Patients presenting early with severe disease have a better neurodevelopmental outcome and lower risk of diabetes if they are treated with early extensive surgery.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12608942     DOI: 10.1046/j.1365-2265.2003.01725.x

Source DB:  PubMed          Journal:  Clin Endocrinol (Oxf)        ISSN: 0300-0664            Impact factor:   3.478


  10 in total

1.  Single incision laparoscopic 90 % pancreatectomy for the treatment of persistent hyperinsulinemic hypoglycemia of infancy.

Authors:  Jin-Shan Zhang; Long Li; Wei Cheng
Journal:  Pediatr Surg Int       Date:  2016-07-29       Impact factor: 1.827

2.  Glucose metabolism in 105 children and adolescents after pancreatectomy for congenital hyperinsulinism.

Authors:  Jacques Beltrand; Marylène Caquard; Jean-Baptiste Arnoux; Kathleen Laborde; Gilberto Velho; Virginie Verkarre; Jacques Rahier; Francis Brunelle; Claire Nihoul-Fékété; Jean-Marie Saudubray; Jean-Jacques Robert; Pascale de Lonlay
Journal:  Diabetes Care       Date:  2011-12-21       Impact factor: 19.112

3.  Hyperinsulinemic hypoglycemia: experience in a series of 17 cases.

Authors:  Sebahat Yılmaz Ağladıoğlu; Senay Savaş Erdeve; Semra Cetinkaya; Veysel Nijat Baş; Havva Nur Peltek Kendirci; Aşan Onder; Zehra Aycan
Journal:  J Clin Res Pediatr Endocrinol       Date:  2013-09-10

4.  Clinical and Genetic Characteristics, Management and Long-Term Follow-Up of Turkish Patients with Congenital Hyperinsulinism.

Authors:  Ayla Güven; Ayşe Nurcan Cebeci; Sian Ellard; Sarah E Flanagan
Journal:  J Clin Res Pediatr Endocrinol       Date:  2015-12-18

5.  Both Low Blood Glucose and Insufficient Treatment Confer Risk of Neurodevelopmental Impairment in Congenital Hyperinsulinism: A Multinational Cohort Study.

Authors:  Annett Helleskov; Maria Melikyan; Evgenia Globa; Inna Shcherderkina; Fani Poertner; Anna-Maria Larsen; Karen Filipsen; Klaus Brusgaard; Charlotte Dahl Christiansen; Lars Kjaersgaard Hansen; Henrik T Christesen
Journal:  Front Endocrinol (Lausanne)       Date:  2017-07-10       Impact factor: 5.555

6.  Intraoperative Ultrasound: A Tool to Support Tissue-Sparing Curative Pancreatic Resection in Focal Congenital Hyperinsulinism.

Authors:  Julie Bendix; Mette G Laursen; Michael B Mortensen; Maria Melikian; Evgenia Globa; Sönke Detlefsen; Lars Rasmussen; Henrik Petersen; Klaus Brusgaard; Henrik T Christesen
Journal:  Front Endocrinol (Lausanne)       Date:  2018-08-22       Impact factor: 5.555

7.  Delayed Resolution of Feeding Problems in Patients With Congenital Hyperinsulinism.

Authors:  Chris Worth; Caroline Hall; Sarah Wilson; Niamh Gilligan; Elaine O'Shea; Maria Salomon-Estebanez; Mark Dunne; Indraneel Banerjee
Journal:  Front Endocrinol (Lausanne)       Date:  2020-03-18       Impact factor: 5.555

8.  Risk Factors for Adverse Neurodevelopment in Transient or Persistent Congenital Hyperinsulinism.

Authors:  Marcia Roeper; Roschan Salimi Dafsari; Henrike Hoermann; Ertan Mayatepek; Sebastian Kummer; Thomas Meissner
Journal:  Front Endocrinol (Lausanne)       Date:  2020-11-30       Impact factor: 5.555

Review 9.  Therapies and outcomes of congenital hyperinsulinism-induced hypoglycaemia.

Authors:  I Banerjee; M Salomon-Estebanez; P Shah; J Nicholson; K E Cosgrove; M J Dunne
Journal:  Diabet Med       Date:  2018-10-08       Impact factor: 4.359

10.  Long-Term Outcome and Treatment in Persistent and Transient Congenital Hyperinsulinism: A Finnish Population-Based Study.

Authors:  Jonna M E Männistö; Jarmo Jääskeläinen; Timo Otonkoski; Hanna Huopio
Journal:  J Clin Endocrinol Metab       Date:  2021-03-25       Impact factor: 5.958

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.